Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)
China · Delayed Price · Currency is CNY 21.10
-0.76 (-3.48%)
Sep 10, 2026, 3:04 PM CST
SHE:002864 Revenue
Shaanxi Panlong Pharmaceutical Group had revenue of 200.04M CNY in the quarter ending June 30, 2026, a decrease of -38.22%. This brings the company's revenue in the last twelve months to 989.42M, down -9.44% year-over-year. In the year 2025, Shaanxi Panlong Pharmaceutical Group had annual revenue of 1.14B with 17.15% growth.
Revenue (ttm)
989.42M
Revenue Growth
-9.44%
P/S Ratio
3.04
Revenue / Employee
1.07M
Employees
926
Market Cap
3.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.14B | 167.01M | 17.15% |
| Dec 31, 2024 | 973.86M | -6.96M | -0.71% |
| Dec 31, 2023 | 980.83M | 6.53M | 0.67% |
| Jan 1, 2023 | 974.29M | 86.81M | 9.78% |
| Jan 1, 2022 | 887.48M | 217.17M | 32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 3.50B |
| Guizhou Yibai Pharmaceutical | 1.56B |
| Anhui Sunhere Pharmaceutical Excipients | 993.60M |
| Zhejiang Cheng Yi Pharmaceutical | 827.47M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 790.94M |
| Jiangxi Synergy Pharmaceutical | 784.40M |
| Chongqing Jiheng Pharmaceutical | 654.22M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 491.90M |